Rahul Banerjee, Assistant Professor at the Fred Hutchinson Cancer Center and at the University of Washington, shared a highlights from ASH25 Annual Meeting on X:
“Now in Orlando: US MM Immunotherapy Consortium gifts (gift cards not shown) for our fearless leaders Dori Shansen, Surbhi Sidana, Krina Patel.
14 orals and 8 posters at ASH25, and many published JCO ASCO & Blood Portfolio papers that they can re-read with morning coffee!
Mugs credit of ScienceGrit – thank you for getting these made on such short notice for ASH25!!”
“ASH Kudos to Urvi Shah for getting this to finish line in time for ASH25! High fiber plant-based diets in myeloma precursors: Something our patients ask about, and something we have data for now! QOL, inflam benefits – and in some cases, alteration of MM trajectory!”
“ASH25 alongside my mentor and fellow top tweeter – and the kindest judge of mon pauvre français lorsque j’ai parlé con Rafael Fonseca à IMS25. Thanks Mohamad Mohty for all of your kindness and mentorship of junior faculty across the Globe.
And shortly after, with an ASH25 photo op with MM celebrity Claudio Cerchione!”
“Alfred Chung updated AURIGA focused on MRD dynamics, including MRD resurgence. Similar to IMROZ data last year by Robert Z. Orlowski … MRD resurgence less common with continued CD38 pressure, even in HR. Another argument in favor of its inclusion in maintenance!”
“ASH police: Murali Janakiram is clearly tweeting while actively moderating his ASH25 session. Joking, of course – these are great data and absolutely worth tweeting about!”
“COBRA = big challenge to ENDURANCE, but no firm answers on KRd vs VRd since PI exposure different. Nevertheless – authors for clearly showing that K 56 1x weekly carries a punch and is manageable! Although no PFS ∆ in ASCT-ineligible, so mainly for younger pts (?).”
“ASH25 thankfully we didn’t put our eggs in one CANOVA basket! Hang Quach continuing to show excellent data for BCL2 inhibition in MM with t(11;14), this time with sonrotoclax. Plays nicely in the sandbox with K!”
“And of course a selfie with Bhausaheb Bagal et al, representing India here in Orlando. Many of the innovations that the world will adopt around cost effectiveness in myeloma and CAR-T will come from India. देसी जुगाड़ से !”
“ASH25 bootcamp for T cells before apheresis for CAR-T! I have to catch up on these sessions – Hamza Hashmi did they see that the improvements in T-cell fitness even happened in pts with known len-refractoriness in terms of MM control?”
“Excellent ASH article by Ben Derman about MRD-guided discontinuation of MM maintenance therapy based on data we have currently (while we await SWOG S1803). I’ve been doing 2 years of len maintenance before these discussions… maybe I should start at 1!.”
Read More Updates from ASH 2025 on OncoDaily.
